212 related articles for article (PubMed ID: 23151803)
1. Regional distribution of SGLT activity in rat brain in vivo.
Yu AS; Hirayama BA; Timbol G; Liu J; Diez-Sampedro A; Kepe V; Satyamurthy N; Huang SC; Wright EM; Barrio JR
Am J Physiol Cell Physiol; 2013 Feb; 304(3):C240-7. PubMed ID: 23151803
[TBL] [Abstract][Full Text] [Related]
2. Functional expression of SGLTs in rat brain.
Yu AS; Hirayama BA; Timbol G; Liu J; Basarah E; Kepe V; Satyamurthy N; Huang SC; Wright EM; Barrio JR
Am J Physiol Cell Physiol; 2010 Dec; 299(6):C1277-84. PubMed ID: 20826762
[TBL] [Abstract][Full Text] [Related]
3. Revisiting the physiological roles of SGLTs and GLUTs using positron emission tomography in mice.
Sala-Rabanal M; Hirayama BA; Ghezzi C; Liu J; Huang SC; Kepe V; Koepsell H; Yu A; Powell DR; Thorens B; Wright EM; Barrio JR
J Physiol; 2016 Aug; 594(15):4425-38. PubMed ID: 27018980
[TBL] [Abstract][Full Text] [Related]
4. Intestinal absorption of glucose in mice as determined by positron emission tomography.
Sala-Rabanal M; Ghezzi C; Hirayama BA; Kepe V; Liu J; Barrio JR; Wright EM
J Physiol; 2018 Jul; 596(13):2473-2489. PubMed ID: 29707805
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the expression and spatial localization of glucose transporters in the rat, bovine and human lens.
Lim JC; Perwick RD; Li B; Donaldson PJ
Exp Eye Res; 2017 Aug; 161():193-204. PubMed ID: 28625822
[TBL] [Abstract][Full Text] [Related]
6. Does 2-FDG PET Accurately Reflect Quantitative In Vivo Glucose Utilization?
Barrio JR; Huang SC; Satyamurthy N; Scafoglio CS; Yu AS; Alavi A; Krohn KA
J Nucl Med; 2020 Jun; 61(6):931-937. PubMed ID: 31676728
[TBL] [Abstract][Full Text] [Related]
7. Comparison of GLUT-1, SGLT-1, and SGLT-2 expression in false-negative and true-positive lymph nodes during the
Taira N; Atsumi E; Nakachi S; Takamatsu R; Yohena T; Kawasaki H; Kawabata T; Yoshimi N
Lung Cancer; 2018 Sep; 123():30-35. PubMed ID: 30089592
[TBL] [Abstract][Full Text] [Related]
8. Sodium-glucose co-transporter (SGLT) and glucose transporter (GLUT) expression in the kidney of type 2 diabetic subjects.
Norton L; Shannon CE; Fourcaudot M; Hu C; Wang N; Ren W; Song J; Abdul-Ghani M; DeFronzo RA; Ren J; Jia W
Diabetes Obes Metab; 2017 Sep; 19(9):1322-1326. PubMed ID: 28477418
[TBL] [Abstract][Full Text] [Related]
9. [(18)F]FDG is not transported by P-glycoprotein and breast cancer resistance protein at the rodent blood-brain barrier.
Wanek T; Traxl A; Bankstahl JP; Bankstahl M; Sauberer M; Langer O; Kuntner C
Nucl Med Biol; 2015 Jul; 42(7):585-9. PubMed ID: 25823393
[TBL] [Abstract][Full Text] [Related]
10. Revised immunolocalization of the Na+-D-glucose cotransporter SGLT1 in rat organs with an improved antibody.
Balen D; Ljubojevic M; Breljak D; Brzica H; Zlender V; Koepsell H; Sabolic I
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C475-89. PubMed ID: 18524944
[TBL] [Abstract][Full Text] [Related]
11. Glucose transport by acinar cells in rat parotid glands.
Jurysta C; Nicaise C; Cetik S; Louchami K; Malaisse WJ; Sener A
Cell Physiol Biochem; 2012; 29(3-4):325-30. PubMed ID: 22508040
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of cerebral glucose metabolic rates after blood-brain barrier disruption induced by focused ultrasound using FDG-MicroPET.
Yang FY; Chang WY; Chen JC; Lee LC; Hung YS
Neuroimage; 2014 Apr; 90():93-8. PubMed ID: 24368263
[TBL] [Abstract][Full Text] [Related]
13. Sodium influx through cerebral sodium-glucose transporter type 1 exacerbates the development of cerebral ischemic neuronal damage.
Yamazaki Y; Harada S; Wada T; Hagiwara T; Yoshida S; Tokuyama S
Eur J Pharmacol; 2017 Mar; 799():103-110. PubMed ID: 28174043
[TBL] [Abstract][Full Text] [Related]
14. A functional role for sodium-dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation.
Vemula S; Roder KE; Yang T; Bhat GJ; Thekkumkara TJ; Abbruscato TJ
J Pharmacol Exp Ther; 2009 Feb; 328(2):487-95. PubMed ID: 18981287
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography of sodium glucose cotransport activity in high grade astrocytomas.
Kepe V; Scafoglio C; Liu J; Yong WH; Bergsneider M; Huang SC; Barrio JR; Wright EM
J Neurooncol; 2018 Jul; 138(3):557-569. PubMed ID: 29525972
[TBL] [Abstract][Full Text] [Related]
16. Sodium-glucose co-transporter (SGLT)2 and SGLT1 renal expression in patients with type 2 diabetes.
Solini A; Rossi C; Mazzanti CM; Proietti A; Koepsell H; Ferrannini E
Diabetes Obes Metab; 2017 Sep; 19(9):1289-1294. PubMed ID: 28419670
[TBL] [Abstract][Full Text] [Related]
17. In Vivo Functional Assessment of Sodium-Glucose Cotransporters (SGLTs) Using [
Matsusaka Y; Chen X; Arias-Loza P; Werner RA; Nose N; Sasaki T; Rowe SP; Pomper MG; Lapa C; Higuchi T
Mol Imaging; 2022; 2022():4635171. PubMed ID: 35903251
[TBL] [Abstract][Full Text] [Related]
18. Sodium-glucose cotransporters: new targets of cancer therapy?
Madunić IV; Madunić J; Breljak D; Karaica D; Sabolić I
Arh Hig Rada Toksikol; 2018 Dec; 69(4):278-285. PubMed ID: 30864374
[TBL] [Abstract][Full Text] [Related]
19. Functional characterisation of human SGLT-5 as a novel kidney-specific sodium-dependent sugar transporter.
Grempler R; Augustin R; Froehner S; Hildebrandt T; Simon E; Mark M; Eickelmann P
FEBS Lett; 2012 Feb; 586(3):248-53. PubMed ID: 22212718
[TBL] [Abstract][Full Text] [Related]
20. Comparison of GLUT1, GLUT2, GLUT4 and SGLT1 mRNA expression in the salivary glands and six other organs of control, streptozotocin-induced and Goto-Kakizaki diabetic rats.
Jurysta C; Nicaise C; Giroix MH; Cetik S; Malaisse WJ; Sener A
Cell Physiol Biochem; 2013; 31(1):37-43. PubMed ID: 23343648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
